A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles

BACKGROUND

Although close observation of serum estradiol (E2) levels remains a mainstay of assessing clinical response to controlled ovarian stimulation, the prognostic value of any change in E2 levels after administration of hCG remains unclear. The objective of this study is to evaluate the relationship between serum E2 response after hCG administration and the clinical pregnancy and live birth rates in fresh IVF cycles.

METHODS

We conducted a retrospective cohort study of women aged 21–45 years undergoing their first IVF cycle from 1999 to 2008 at a single practice. We compared the post-hCG serum E2 level with values on the day of hCG trigger. IVF cycles were stratified by post-hCG E2 response and appropriate parametric and non-parametric statistics were performed. Clinical intrauterine pregnancy and live births were the primary outcomes of interest. Multivariable logistic regression models were created to identify predictive factors associated with outcomes while adjusting for potential confounders.

RESULTS

Among the 1712 IVF cycles, 1065 exhibited a >10% increase (Group A), 525 had a plateau (±10%, Group B) and 122 showed a >10% decrease (Group C) in post-hCG E2 levels. While the E2 levels on the day of hCG were similar across groups, Group C had more patients with diminished ovarian reserve, required higher gonadotrophin doses and had the lowest implantation rates. After adjusting for age, total gonadotrophin dose, infertility diagnosis, number of oocytes and number of transferred embryos, the associations between post-hCG E2 decline (Group C) and clinical pregnancy [adjusted odds ratio (aOR): 0.53; 95% confidence interval (CI): 0.33–0.84, P= 0.007] and live birth (aOR: 0.40; 95% CI: 0.22–0.71, P= 0.002) were significant. We also found significant associations between E2 plateau (Group B) and clinical pregnancy (aOR: 0.73; 95% CI: 0.57–0.94, P= 0.013) and live birth (aOR: 0.74; 95% CI: 0.56–0.97, P= 0.032) when adjusting for the same factors.

CONCLUSIONS

In our study, >10% decrease in E2 levels after hCG administration was associated with 40–50% reduction in clinical pregnancy and live birth rates. Similarly, post-hCG E2 plateau (±10%) lowered the clinical pregnancy and live birth rates by >25%. Our study suggests that the change in the post-hCG E2 level is another parameter that can be used by clinicians to counsel patients regarding their likelihood of success with assisted reproductive technologies prior to oocyte retrieval.

Source:
http://humrep.oxfordjournals.org/rss/current.xml

Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis

Background

At present, the only way to conclusively diagnose endometriosis is laparoscopic inspection, preferably with histological confirmation. This contributes to the delay in the diagnosis of endometriosis which is 6–11 years. So far non-invasive diagnostic approaches such as ultrasound (US), MRI or blood tests do not have sufficient diagnostic power. Our aim was to develop and validate a non-invasive diagnostic test with a high sensitivity (80% or more) for symptomatic endometriosis patients, without US evidence of endometriosis, since this is the group most in need of a non-invasive test.

Methods

A total of 28 inflammatory and non-inflammatory plasma biomarkers were measured in 353 EDTA plasma samples collected at surgery from 121 controls without endometriosis at laparoscopy and from 232 women with endometriosis (minimal–mild n = 148; moderate–severe n = 84), including 175 women without preoperative US evidence of endometriosis. Surgery was done during menstrual (n = 83), follicular (n = 135) and luteal (n = 135) phases of the menstrual cycle. For analysis, the data were randomly divided into an independent training (n = 235) and a test (n = 118) data set. Statistical analysis was done using univariate and multivariate (logistic regression and least squares support vector machines (LS-SVM) approaches in training- and test data set separately to validate our findings.

Results

In the training set, two models of four biomarkers (Model 1: annexin V, VEGF, CA-125 and glycodelin; Model 2: annexin V, VEGF, CA-125 and sICAM-1) analysed in plasma, obtained during the menstrual phase, could predict US-negative endometriosis with a high sensitivity (81–90%) and an acceptable specificity (68–81%). The same two models predicted US-negative endometriosis in the independent validation test set with a high sensitivity (82%) and an acceptable specificity (63–75%).

Conclusions

In plasma samples obtained during menstruation, multivariate analysis of four biomarkers (annexin V, VEGF, CA-125 and sICAM-1/or glycodelin) enabled the diagnosis of endometriosis undetectable by US with a sensitivity of 81–90% and a specificity of 63–81% in independent training- and test data set. The next step is to apply these models for preoperative prediction of endometriosis in an independent set of patients with infertility and/or pain without US evidence of endometriosis, scheduled for laparoscopy.

Source:
http://humrep.oxfordjournals.org/rss/current.xml

National survey of the current management of endometriomas in women undergoing assisted reproductive treatment

STUDY QUESTION

What is the current management of women with ovarian endometriomas undergoing assisted reproductive treatment (ART) in the UK?

SUMMARY ANSWER

It appears that the majority of gynaecologists in the UK offer surgery (mostly cystectomy) for endometriomas prior to ART, regardless of the presence of symptoms.

WHAT IS KNOWN ALREADY

The ideal management of endometriomas in women undergoing ART remains controversial and presents a dilemma to reproductive specialists.

STUDY DESIGN, SIZE AND DURATION

This was a national cross-sectional survey. A total of 388 gynaecologists completed the questionnaire.

PARTICIPANTS, SETTINGS AND METHODS

All clinicians fully registered with the Royal College of Obstetricians and Gynaecologists were contacted. An 11-item survey was administered electronically using Survey Monkey software. Quantitative data were analysed using descriptive and comparative statistics.

MAIN RESULTS AND THE ROLE OF CHANCE

The majority of responders were consultants (65%), 25% practiced ART and 65% performed laparoscopic surgery. Overall, 95% of responders would offer surgery for endometriomas in women undergoing ART, either on the basis of the size (>3–5 cm) of the endometrioma (52%), the presence of symptoms (16%), the presence of multiple/bilateral endometriomas (2%), regardless of the size and symptoms (19%) or only to women undergoing IVF (6%). The remaining 5% of responders would not offer surgery before ART. Excision was the most common surgical modality (68%), followed by ablation (25%). Laparoscopic surgeons were almost twice as likely to ‘offer surgery to all patients with endometriomas prior to ART’ compared with clinicians performing laparotomy (22 versus 12%, P < 0.001).

LIMITATIONS, REASONS FOR CAUTION

Our overall response rate, with answers to the questionnaire, was low (15%). However, the response rate amongst reproductive specialists was estimated at 60%. It is possible that there might have been an element of bias towards over-representation of responders who are more concerned about ‘normalization’ of the pelvic anatomy. Furthermore, our survey relied on self-reporting of practice and it is possible that being presented with a list of ‘ideal’ options may have resulted in respondent bias.

WIDER IMPLICATIONS OF THE FINDINGS

Despite the available evidence that surgery for endometriomas does not improve the outcome of ART and may damage ovarian reserve, it seems that the majority of gynaecologists in the UK offer ovarian cystectomy to their patients.

STUDY FUNDING/COMPETING INTERESTS

None.

Source:
http://humrep.oxfordjournals.org/rss/current.xml

Psychological stress and reproductive aging among pre-menopausal women

BACKGROUND

Life history models suggest that biological preparation for current versus longer term reproduction is favored in environments of adversity. In this context, we present a model of reproductive aging in which environmental adversity is proposed to increase the number of growing follicles at the cost of hastening the depletion of the ovarian reserve over time. We evaluated this model by examining psychological stress in relation to reproductive aging indexed by antral follicle count (AFC), a marker of total ovarian reserve. We hypothesized that stress would be related to (i) higher AFC in younger women, reflecting greater reproductive readiness as well as (ii) greater AFC loss across women, reflecting more accelerated reproductive aging.

METHODS

In a multi-ethnic, community sample of 979 participants [ages 25–45 (mean (standard deviation) = 35.2 (5.5)); 27.5% Caucasian] in the Ovarian Aging study, an investigation of the correlates of reproductive aging, the interaction of age-x-stress was assessed in relation to AFC to determine whether AFC and AFC loss varied across women experiencing differing levels of stress. Stress was assessed by the perceived stress scale and AFC was assessed by summing the total number of antral follicles visible by transvaginal ultrasound.

RESULTS

In linear regression examining AFC as the dependent variable, covariates (race/ethnicity, socio-economic status, menarcheal age, hormone-containing medication for birth control, parity, cigarette smoking, bodymass index, waist-to-hip ratio) and age were entered on step 1, stress on step 2 and the interaction term (age-x-stress) on step 3. On step 3, significant main effects showed that older age was related to lower AFC (b = –0.882, P = 0.000) and greater stress was related to higher AFC (b = 0.545, P = 0.005). Follow-up analyses showed that the main effect of stress on AFC was present in the younger women only. A significant interaction term (b = –0.036, P = 0.031) showed the relationship between age and AFC varied as function of stress. When the sample was divided into tertiles of stress, the average follicle loss was –0.781, –0.842 and –0.994 follicles/year in the low-, mid- and high-stress groups, respectively.

CONCLUSIONS

Psychological stress was related to higher AFC among younger women and greater AFC decline across women, suggesting that greater stress may enhance reproductive readiness in the short term at the cost of accelerating reproductive aging in the long term. Findings are preliminary, however, due to the cross-sectional nature of the current study.

Source:
http://humrep.oxfordjournals.org/rss/current.xml

Psychometric properties of the Iranian version of modified polycystic ovary syndrome health-related quality-of-life questionnaire

STUDY QUESTION

Can the modified polycystic ovary syndrome health-related quality-of-life questionnaire (MPCOSQ) be validated in Iranian patients with polycystic ovary syndrome (PCOS) to provide an instrument for future outcome studies in these patients?

SUMMARY ANSWER

We show initial reliability and validity of the Iranian version of the MPCOSQ as a specific instrument to measure health-related quality of life (QOL) in patients with PCOS in Iran.

WHAT IS KNOWN ALREADY

The prevalence of PCOS in Iran is relatively high and studying QOL in these patients is important. The PCOSQ has previously been translated and validated in Iran but no studies had examined the psychometric properties of the MPCOSQ in Iran.

STUDY DESIGN, SIZE, AND DURATION

This was a cross-sectional study. After linguistic validation of the Iranian version of MPCOSQ, an expert panel evaluated the items by assessing the content validity index (CVI) and content validity ratio (CVR). Then a semi-structured interview was conducted to assess face validity. Consequently, exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) were performed to indicate the scale constructs (n = 200). In addition, reliability analyses including internal consistency and test–retest analysis were carried out.

PARTICIPANTS/MATERIALS, SETTING, AND METHODS

This study was carried out on women with PCOS (n = 200) who attended two private gynecology clinics in Kashan, Iran. Patients were eligible if they met each of the following criteria: 15–40 years of age; married; not having non-classic adrenal hyperplasia, thyroid dysfunction and hyperprolactinemia; Iranian; not having problems in speaking or listening; having two of the following Rotterdam diagnostic criteria: (i) polycystic ovaries visualized on ultrasound scan (presence of 12 follicles or more in one or both ovaries and/or increased ovarian volume >10 ml), (ii) clinical signs of hyperandrogenism (the hirsutism score based on the Ferriman–Gallwey score >7 or obvious acne) and/or an elevated plasma testosterone (normal range testosterone <2 nmol/l), (iii) having an interval between menstrual periods >35 days and/or amenorrhea as the absence of vaginal bleeding for at least 6 months, i.e. 199 days.

MAIN RESULTS AND THE ROLE OF CHANCE

CVI and CVR scores for MPCOSQ were 0.96 and 0.92, respectively. A six-factor solution (emotional disturbance, weight, infertility, acne, menstrual difficulties and hirsutism) emerged as a result of an EFA and explained 0.64% of the variance observed. The result of the EFA supported the item ‘late menstrual period’ being placed in the menstrual rather than the emotional subscale. The results of the CFA for six-factor model for MPCOSQ indicated an acceptable fit for the proposed model. Additional analyses indicated satisfactory results for internal consistency (Cronbach's alpha ranging from 0.76 to 0.92) and intraclass correlation coefficients (ranging from 0.71 to 0.92). Moving ‘late menstrual period’ from the emotional to the menstrual subscale significantly improved the reliability coefficient for both subscales.

LIMITATIONS, REASONS FOR CAUTION

Study of patients with PCOS attending two private gynecology clinics may limit generalization of the findings to the entire population with PCOS. All patients in this study were married for cultural reasons in Iran. Therefore, the results of the present study have to be interpreted with some caution.

WIDER IMPLICATIONS OF THE FINDINGS

The Iranian version of the MPCOSQ will fill an important gap in measuring the QOL in patients with PCOS in the research and community settings in Iran.

STUDY FUNDING/COMPETING INTEREST(S)

The authors declare that they have no conflict of interest.

Source:
http://humrep.oxfordjournals.org/rss/current.xml

Expression of adhesion, attachment and invasion markers in eutopic and ectopic endometrium: a link to the aetiology of endometriosis

BACKGROUND

Cell properties, such as attachment, adhesion and invasion, are important for the normal function of the endometrium. However, it is believed that the same properties may also be involved in the development of gynaecological diseases, such as endometriosis. Endometrial cells, shed by retrograde menstruation, may have an aberrant expression of molecules involved in these functions, leading to endometriosis. Therefore, the aim of this study was to investigate the expression of proteins involved in adhesion, attachment and invasion in eutopic and ectopic endometrium.

METHODS

Endometrial biopsy specimens were collected from healthy volunteers (controls: proliferative phase, n = 10; secretory phase, n = 15) and from endometriosis patients (proliferative phase: n = 9, secretory phase: n = 10). Biopsy specimens from endometriomas were also collected (proliferative phase: n = 9, secretory phase: n = 10). Expression of apolipoprotein E (ApoE), integrin β-2 (ITGB2), integrin β-7 (ITGB7), Laminin -1 (LAMC1), CD24 molecule (CD24) and junctional adhesion molecule-1 (JAM-1) was evaluated with real-time reverse transcriptase polymerase chain reaction and immunohistochemistry.

RESULTS

The endometrium from controls and women with endometriosis expressed ApoE, ITGB2, ITGB7, LAMC1, CD24 and JAM-1. Gene expression of ApoE and JAM-1 was decreased in both proliferative and secretory phase in the endometrium from women with endometriosis compared with control endometrium. Also, mRNA expression of LAMC1 was reduced in the endometrium from endometriosis patients compared with controls in the proliferative phase. An altered gene expression of CD24 was seen between the endometrium from endometriosis patients and endometriomas in the secretory phase. The ITGB2 protein expression was altered in epithelia cells between the endometrium from healthy volunteers and endometriosis patients in the secretory phase.

CONCLUSIONS

We have shown differential expression of adhesion, attachment and invasion proteins in proliferative and secretory endometrium from controls and endometriosis patients and in endometriomas. This study suggests that molecules with these properties may have a role in the anchoring of endometrial cells at ectopic sites, thus initiating the development of endometriosis.

Source:
http://humrep.oxfordjournals.org/rss/current.xml

Vitamin D and cancer – nine facts "they" won’t tell you

by: Aurora Geib
Before, to be diagnosed with the big C seemed to be an implied death sentence. Patients even go through a stage of self-denial. Who can blame them? Conventional medicine paints a rather bleak future for cancer patients and the remedy it offers does nothing to improve their quality of life, nausea and falling hair not to mention.
However, the recent breakthroughs in science have allowed a peek into the true nature of cancer, allowing researchers to consider the concept of nutritional care. They are now faced with the idea that preventing and maybe even reversing cancer may not necessarily involve the development of expensive drugs but something already available in nature: food and sunshine! (http://dreddyclinic.com/forum/viewtopic.php?f=14&t=3)
Just the facts
If something so powerful is actually available for everyone, why wouldn't someone take advantage of it?
The recent discovery that the body, with the help of vitamin D, possesses the capacity to fight many chronic illnesses has spurred the interest of many researchers - especially on the possibilities the sunshine vitamin can offer with regard to the prevention and reversal of diseases like cancer. A brief rundown of some facts, revealed by recent studies, can give us a perspective on how vitamin D can help.Read more…

Source:
http://anti-aging-for-today.blogspot.com/feeds/posts/default?alt=rss

Vitamin D and cancer – nine facts "they" won't tell you

by: Aurora Geib
Before, to be diagnosed with the big C seemed to be an implied death sentence. Patients even go through a stage of self-denial. Who can blame them? Conventional medicine paints a rather bleak future for cancer patients and the remedy it offers does nothing to improve their quality of life, nausea and falling hair not to mention.
However, the recent breakthroughs in science have allowed a peek into the true nature of cancer, allowing researchers to consider the concept of nutritional care. They are now faced with the idea that preventing and maybe even reversing cancer may not necessarily involve the development of expensive drugs but something already available in nature: food and sunshine! (http://dreddyclinic.com/forum/viewtopic.php?f=14&t=3)
Just the facts
If something so powerful is actually available for everyone, why wouldn't someone take advantage of it?
The recent discovery that the body, with the help of vitamin D, possesses the capacity to fight many chronic illnesses has spurred the interest of many researchers - especially on the possibilities the sunshine vitamin can offer with regard to the prevention and reversal of diseases like cancer. A brief rundown of some facts, revealed by recent studies, can give us a perspective on how vitamin D can help.Read more…

Source:
http://anti-aging-for-today.blogspot.com/feeds/posts/default?alt=rss

New SprintPic™ Macro Imaging System from SPOT Imaging Solutions

Sprint Pic

The new SPOT SprintPic turnkey macro imaging system makes it effortless to capture great images, increasing efficiency and saving photography time.   Including a scientific grade digital camera with a software-controlled motorized zoom lens on a lighted copy stand, the SprintPic system is preconfigured and ready to use so you can get up and running quickly.  Its large number of zoom levels accommodates a wide range of samples, from industrial parts to crime scene evidence to pathology grossing sections.  The SprintPic Software provides a monitor-sized live image preview with sliders for adjusting zoom level and iris aperture, so it’s easy to see when your sample is ready for capture.  Crosshair and grid reticles can be applied to the live preview to aid in counting or for visual inspection of part size.  When you snap a photo, it is immediately ready for adding annotations, measurements, or for saving to reports - no need to wait for images to download.   Images can be automatically transferred to laboratory information systems or saved to network file servers for archival.  Built-in high-output oblique and bottom lighting ensures true color reproduction and shadow removal.  The SprintPic macro imaging system takes the guesswork out of digital documentation.

SPOT Imaging Solutions

http://www.spotimaging.com/sprintpic

586-731-6000

 

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Zoom tool stitches together thousands of nanoscopic cell images

By Liat Clark Courtesy of WIRED.CO.UK

07 August 12
Image1
A team of molecular biologists has published a paper revealing how its "virtual nanoscopy" method creates detailed, high resolution images of cellular structures by "stitching" together thousands of electron microscope photos.

Electron microscopes can magnify an image by up to 10 million times using beams of electrons. However, the tool can only be used to either capture a single, detailed image of part of a cell or, at a lower resolution, a less-detailed overview of the cell. There was no way, until now, to relate the one to the other and give a contextual and detailed overview of the entire cell structure at once.

In the paper Virtual nanoscopy: Generation of ultra-large high resolution electron microscopy maps, Leiden University Medical Centre molecular biologist Frank Faas and his team explain how they have enabled "unbiased high resolution data access while maintaining the lower resolution overview of the cellular context". It's a little like Google Earth's zoom tool, but for cell biologists.

The team joined together 26,434 detailed photos of a 1.5 millimetre-long zebrafish embryo taken using an FEI Eagle CCD camera linked up to an electron microscope. The total data of all the photos that made up the full embryo picture amounted to 281 gigapixels, with a resolution of 16 million pixels per inch -- to visualise just what incredible detail that resolution offers, compare that pixel count to the 220 pixel-per-inch resolution boasted by Apple's new Retina display Macbook Pro. Seems pretty paltry now, doesn't it. The final image slide was created using a program specifically developed for the task -- MyStitch extracts metadata from transmission electron microscopy (TEM) images and uses this to pair the images, noting any overlaps and adjusting the joins appropriately. Images have been stitched together in a similar manner in the past, using tools such as Adobe Photoshop, but only on a much smaller scale. Generating a full image of a cellular structure calls for huge amounts of time-consuming data collection, so the team achieved its feat by automating some of the processes, from the data-stitching down to the photo-taking.

The final image has been published at the upgraded JCB DataViewer site where interested parties can play around with the zoom function and take in not only the embryo, but images of mouse glomeruli, human dendritic cells and mouse embryonic fibroblasts.

Medical professionals often zoom in on the part of a cell they believe to be the main area of focus, or the root of a problem. By presenting a comprehensive image, the new "virtual nanoscopy" method ensures they get the whole picture and do not miss or inadvertently skim over important elements.

"Virtual nanoscopy does not suffer from sparse or possibly biased selection of regions of interest for high resolution imaging," states the paper. "[It] provides an objective and representative approach to record, communicate, and share data of large areas of biological specimens at nanometre resolution."

And in a related story from newswise (Rockefeller University Press):

Virtual Nanoscopy: Like “Google Earth” for Cell Biologists

Just as users of Google Earth can zoom in from space to a view of their own backyard, researchers can now navigate biological tissues from a whole embryo down to its subcellular structures thanks to recent advances in electron microscopy and image processing, as described inThe Journal of Cell Biology (JCB). An upgrade to the JCB DataViewer (http://jcb-dataviewer.rupress.org), JCB’s browser-based image presentation tool, now also makes these data publicly accessible for exploration and discovery.

Since the early days of cell biology, electron microscopy has revealed cellular structures in exquisite detail. The technique has always been limited, however, by the fact that it can only capture a tiny portion of the cell in a single image at high resolution, making it difficult for researchers to relate the structures they see to the cell as a whole, let alone to the tissue or organ in which the cell is located. Viewing samples at lower resolution, on the other hand, can reveal the larger picture of a cell or tissue, but researchers then lose the benefit of seeing fine details.

A team of scientists from Leiden University Medical Center in the Netherlands has addressed this problem by developing new tools for stitching together thousands of electron microscopy images into single, high-resolution images of biological tissues—a “Google Earth” for cell biologists—which can be explored using the newly enhanced JCB DataViewer.

Faas et al. describe their recent advances to a technique called “virtual nanoscopy” in the August 6th issue of JCB. The researchers were able to stitch together over 26,000 individual images to generate an almost complete electron micrograph of a zebrafish embryo encompassing 281 gigapixels in total at a resolution of 16 million pixels per inch. Using the JCB DataViewer, anyone can navigate the zebrafish image from the level of the whole, 1.5 millimeter-long embryo down to subcellular structures.

The ability to integrate information across cells and tissues will provide researchers with exceptional opportunities for future discoveries. But the image’s large size and complexity meant that providing access to Faas et al.’s data necessitated a major upgrade to the JCB DataViewer, a browser-based image hosting platform originally launched in 2008 to promote the sharing of original data associated with JCB publications.

“If you can image it, you should be able to publish it,” says JCB Executive Editor Liz Williams. As a journal, “JCB remains committed to developing cutting-edge tools for the presentation of the data that drive progress in the field of cell biology.”
# # #
About The Journal of Cell Biology 
Founded in 1955, The Journal of Cell Biology (JCB) is published by The Rockefeller University Press. All editorial decisions on manuscripts submitted are made by active scientists in conjunction with our in-house scientific editors. JCB content is posted to PubMed Central, where it is available to the public for free six months after publication. Authors retain copyright of their published works and third parties may reuse the content for non-commercial purposes under a creative commons license. For more information, please visit http://www.jcb.org.

About the JCB DataViewer
The JCB DataViewer is an image hosting and presentation platform for original image data associated with articles published in JCB. Developed in a collaboration between Glencoe Software, Inc. (www.glencoesoftware.com) and the Rockefeller University Press (www.rupress.org), the JCB DataViewer was the first browser-based viewer for multidimensional microscopy image data. It is based on open source software built by the Open Microscopy Environment (OME; http://openmicroscopy.org).

Faas, F.G.A., et al. 2012. J. Cell Biol. doi:10.1083/jcb.201201140
Williams, E.H., et al. 2012. J. Cell Biol. doi:10.1083/jcb.201207117

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Submit your Visions Poster Presentation by August 31


Image006
 
2012 PATHOLOGY VISIONS POSTER PRESENTATIONS
Deadline for Poster Abstract Submissions is August 31, 2012

Don’t miss the opportunity to submit an abstract for a poster presentation at the Digital Pathology Association’s (DPA) annual conference Pathology Visions, which will be held October 28-31, 2012 at the Hilton Baltimore in Baltimore, MD. Presented posters at Pathology Visions will be displayed for two days and discussed between presenters and meeting attendees. The posters will also be judged by appointed experts in the following categories:

- “Best Poster By a Resident”
- “Best Poster Submitted in the
   Research Category”
- “Best Poster Submitted in the
   Education Category”
- “Best Poster Submitted in the
   Clinical Category”
- “Peoples’ Choice Best Poster”

Awards will be handed out to the winner of
each category at Pathology Visions and a
cash prize will be given to the winner of the Resident category.

The deadline for poster abstract submissions is August 31, 2012. Click below to submit your poster abstract now.

 Image006

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Automated, Reagent- and Scanner Independent CE-IVD Module for Her2-IHC Assessment in Breast Cancer – Validated on Data from More than 170 Pathology Labs

Visiopharm A/S, a global leader in Quantitative Digital Pathology, announced today release of its novel CE-IVD module HER2-CONNECT for assessing Her2 status in breast cancer patients

Without any requirements for manual outlining of tumor cells, the level of automation is very high.

Quote startIn summary, HER2-CONNECT™ showed 94% agreement with manual scoring and 95% diagnostic sensitivity and 99% diagnostic specificity.Quote end

Hoersholm, Denmark (PRWEB) August 07, 2012

As the first in a series of innovative CE-IVD diagnostic modules for cancer, Visiopharm is now releasing the HER2-CONNECT™ module in Europe for assessment of Her2 status in breast cancer patients.

In close collaboration with the NordiQC, the clinical performance of HER2-CONNECT has been determined by three studies comprising 796 tissue specimens prepared from breast carcinomas from 222 patients, using 6 expert reviewers/pathologists and representing 178 clinical pathology laboratories using DAKO, Roche-Ventana, Leica-Bond, and other HER2 IHC reagents. In summary, HER2-CONNECT™ showed 94% agreement with manual scoring and 95% diagnostic sensitivity and 99% diagnostic specificity.

Without any requirements for manual outlining of tumor cells, the level of automation is very high. Automation is achieved using a novel and patent pending principle of membrane connectivity for membranes detected in the tissue under examination [1,2 ].

Professor Mogens Vyberg, Director of the NordiQC, states: “Three requirements must be met in order for Digital Pathology to be useful in a routine diagnostic setting: It must be independent of reagent manufacturer and based on optimized and standardized staining procedures, exhibit high diagnostic performance in terms of sensitivity and specificity, and finally it must provide a high degree of automation. Our studies, of which some are still under preparation for publication, have demonstrated that the HER2-CONNECT™ module meet those requirements”.

"This is our first CE-IVD module in a series of modules coming out of our development pipeline. In our development, we are focusing on robustness, diagnostic quality, and last but not least automation. The critical step here is clinical validation and technical documentation. Visiopharm has invested significant resources in establishing the internal procedures and a quality system allowing us to develop, validate, and release CE-IVD modules for diagnostics in Europe", adds Johan Doré, CTO and co-founder of Visiopharm.

“We have now established the necessary platforms for rapid development of new image analysis algorithms and for providing comprehensive technical and clinical documentation. This will allow us to further accelerate an ambitious development program for new innovative techniques in diagnostics and companion diagnostics. We are doing that in collaboration with what we consider to be world-leaders in quality- and evidence based pathology”, says Michael Grunkin, CEO and co-founder of Visiopharm.

1. Brügmann, A., Eld, M., Lelkaitis, G., Nielsen, S., Grunkin, M., Hansen, J.D., Foged, N.T. & Vyberg, M., Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains. Breast Cancer Res Treat. 2012; 132:41-9. 
2. Laurinaviciene, A., Dasevicius, D., Ostapenko, V., Jarmalaite, S., Lazutka, J. & Laurinavicius, A. Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays. Diagn Pathol, 2011, Vol. 6, pp. 87. 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Mayo Clinic Settles Billing Lawsuit

According to the The Pathology Blawg this matter I first talked about in October 2010 has been settled by Mayo Clinic for $1.26 million.

Suit Alleges Mayo Overbilled for Pathology Services, Justice Department Joins Suit (Originally posted October 2010)

The below news item has been circulating for a couple of weeks following a suit originally filed about 3 years ago.  Several folks have asked me what I know about this.  

Did Mayo intentionally defraud the government of potentially millions of dollars for frozen sections not performed?

It is a difficult question to answer and I really do not know how strong the lawsuit claim is. 

I do not think Mayo intentionally would do this but it is a complicated issue.

The story actually begins about 100 years ago when Dr. Louis B. Wilson, credited with being the Father of Research at Mayo Clinic, developed the first techniques to rapidly fix tissue for sectioning during surgery at the request of Dr. William Mayo or what we recognize in pathology as the "frozen section". His techniques live on at Mayo today much like they did over 100 years ago.  The history of the procedure has recently been reviewed with reference to the original article by Dr. Wilson.

Enough history.  Fast forward about 100 years and according to Mayo's GME FAQ's on the frozen section practice it mentions: "The frozen section rotation is probably best thought of as neither a frozen section rotation nor a general surgical pathology rotation, and perhaps that is why residents have come to refer to it as the “sink” rotation. The volume and variety of specimen material seen by residents while on the sink is comparable to what would be seen during a general surgical pathology rotation at a large medical center, yet the workflow is that of a frozen section laboratory. " The site goes on to mention " In the Mayo frozen section labs, a single-color toluidine stain is used because it produces a fast and easily readable stain. The toluidine blue stain produces a slightly different staining pattern compared to H&E, but the morphologic features are inherent to the tissue."

I never understood "morphologic features are inherent to the tissue".  Histology is artifact.  We create it with dyes - a chemical process creates purple nuclei and pink cytoplasm.  In the case of toluidine blue stain, as above, it is largely monochromatic with less contrast than traditional H&E stains, whether frozen or fixed.  

Until recently, with increasing pressure from CAP inspectors, slides reviewed at frozen may not have had a corresponding H&E permanent slide to review for frozen-final correlation.  The tissue used in the frozen section was "blocked" without making an H&E slide.  Again, the practice is unique and would be difficult to validate in many other labs if one takes an objective view.

It also turns out that given the water based nature of the stain and the stain itself it was difficult to make a "permanent" slide for later review as the stain may continue to permeate the tissue.

Given the unique practice, essentially a general surgical pathology practice with final diagnosis made on frozens at the time of surgery rather than "permanent" sections,  issues related to frozen section slides, blocks and permanent slides could all potentially complicate billing algorithms as the suit alleges.  

While the parties bringing forth the suit and the Justice Department are looking at the letter of the law, a persistent question will remain whether whatever may have happened here in regards to billing was justifiable (i.e. cost effective) given potential lack of need for second surgeries, immediate intraoperative staging and overall costs to the system for additional laboratory technical and professional resources to generate additional slides, reviews and reports as compared to outcomes in a "frozen section = final diagnosis" practice alone.  This practice is highlighted on Mayo's breast cancer website:

"Mayo Clinic physicians may use frozen section evaluation of tissue during breast cancer surgery to determine whether all of the cancer has been removed. Mayo Clinic's unique frozen section pathology laboratory provides rapid, accurate microscopic analysis of tissue while the patient is in surgery. Mayo surgeons know if they have achieved negative margins (removed all the cancer) while the patient is still in the operating room. Frozen section analysis may prevent the need for patients to undergo additional surgery."

It should be noted from a similar story out of Minneapolis -- "The Justice Departmentindicated in a September 21 court filing that it intends to intervene in the allegation that the Mayo Clinic billed for services that were not performed. The department will not become involved, however, in the claims that the Mayo Clinic improperly obtained laboratory accreditation and failed to retain histopathology slides for the appropriate time period.

Courtesy of genomeweb.com:

The Justice Department has joined a lawsuit against the Mayo Clinic alleging it submitted fraudulent claims to Medicare and Medicaid for thousands of surgical pathology tests over 10 years that its labs never performed.

The government's position, filed this week under the federal False Claims Act in a US District Court in Minneapolis, said that "over the course of the last 10 years, Mayo has routinely billed Medicare, Medicaid and other federally sponsored health care programs for surgical pathology services that have not been performed," according to the Pittsburgh Tribune-Review.

The suit, which was originally filed in November 2007 by attorney and neurologist David Ketroser, accuses Mayo of billing Medicare for permanent specimen slides and for examining the slides, "even though no slides were prepared or examined," the paper says. "Instead, the suit charges, Mayo routinely prepared only frozen section slides, which were not retained."

The suit also claims Mayo failed to comply with federal regulations that require clinical lab to retain pathology slides for 10 years.

The plaintiffs in the suit include former Mayo patients, survivors of deceased Mayo patients, and Minnesota attorney David Ketroser.

Mayo officials did not respond to a request for comment, according to the Tribune-Review.

A few days after its original report, the paper wrote that Mayo officials said the Clinic reimbursed the government for what the paper called "billing errors" on the pathology tests.

Mayo spokesman Bryan Anderson said Minnesota-based Mayo discovered the errors three years ago — "long before Mayo became aware that the sealed complaint [against it] had been filed" — and "voluntarily" refunded $242,711, the paper said.

The total amount of Mayo's alleged fraudulent billing was not immediately clear.

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

23andMe Submits Genetic Test Applications with the FDA

Courtesy of DarkDaily:


45380_web
23andMe executives want the credibility that FDA clearance provides for its DNA tests and declared their intent to eventually support more clinical laboratory test applications

Offering genetic tests directly to consumers is a controversial subject among some pathologists and healthcare ethics experts, who question both the science of these tests and whether consumers will do the right thing with the information.

Read more from the source.

 45380_web

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Natural-language processing tool flags breast, prostate cancer

August 3, 2012 | By Susan D. Hall FierceHealthIT

Researchers claimed success using an SAS-based natural-language processing (NLP) tool to detect breast and prostate cancers from pathology reports, according to a study published this week in the Journal of the American Medical Informatics Association.

Results from the SAS-based coding, extraction, and nomenclature tool (SCENT) were compared with a random sample of 400 breast and 400 prostate cancer patients diagnosed at Kaiser Permanente Southern California whose results were classified manually.

SCENT successfully identified 51 of 54 primary and 60 of 61 recurrent cancers. It flagged only three false positives from 793 known benign results. Measures of sensitivity, specificity, positive predictive value, and negative predictive value exceeded 94 percent in both cancer groups.

White Paper: Improving Patient Outcomes Through a More Effective Electronic Medical Record

SPONSORED BY: GE

Using Electronic Medical Records (EMR) instead of paper files has the potential to improve care for patients by boosting communication. Despite positive results related to EMR usage, questions remain. How can physician practices best use EMRs to focus business and clinical operations, improve outcomes and engage patients in healthcare decision making? Learn more.

The authors noted that previous research has found natural language processing tools useful in coding and extracting information from clinical text. Indeed a recent paper published in Radiology cited success with a tool to parse data from records to build a repository of data to improve dosing recommendations.

They attributed the slow rate of adoption, however, to difficulty in integration with clinical data systems, technical complexity, and habitual use of medical claims data.

Creating a common dictionary of terms can be painstaking work as illustrated in a study on the use of NLP in breast cancer research published recently in theJournal of Pathology Informatics. It reported 124 ways of saying "invasive ductal carcinoma" and 95 ways of saying "invasive lobular carcinoma" and more than 4,000 ways of saying invasive ductal carcinoma was not present.

The authors noted the system probably would require tweaking to work with clinical text in other medical areas and outside of Kaiser Permanente, but the system "has the potential to provide significant value to clinical and epidemiologic researchers, particularly when statistical NLP is infeasible due to resource or other constraints."

A second article on natural language processing in JAMIA found the technology effective for de-identifying clinical health data for research, promising relief from the tedium of manually coding records from which personal information had been scrubbed.

While much data for research remains outside machine-readable formats, platforms enabling comparative-effectiveness research too often lack natural- language processing capabilities, according to a Medical Care study.

To learn more:
- read the research
- check out the Journal of Pathology Informatics study

Related Articles:
Studies show data mining's promise for radiology dose monitoring
Natural-language processing effective for de-identifying clinical health data
Platforms for comparative effectiveness research still evolving

Read more: Natural-language processing tool flags breast, prostate cancer - FierceHealthIT http://www.fiercehealthit.com/story/natural-language-processing-tool-flags-breast-prostate-cancer/2012-08-03#ixzz22jOsB2kk 

Subscribe: http://www.fiercehealthit.com/signup?sourceform=Viral-Tynt-FierceHealthIT-FierceHealthIT

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Quay Brothers Retrospective in New York City! "On Deciphering the Pharmacist's Prescription for Lip-Reading Puppets," Museum of Modern Art, NYC

I just had the honor to view the beautifully installed and revelatory Quay Brothers retrospective "On Deciphering the Pharmacist's Prescription for Lip-Reading Puppets" at the Museum of Modern Art in New York. I have long been a fan of the Quay's work, and still, this exhibition had much to astonish, delight and surprise, situating the Quay's work within the larger context of an avant-garde tradition, and revealing the Quay's oeuvre to be much broader and richer than expected. Surprises and highlights included pen and ink drawings evoking a slightly less whimsical Edward Gorey, a mini-exhibition of the of the kind of Polish theater posters from the 1960s which inspired much of their work, and paintings by a scientific illustrator who mentored them in high school. Also of special interest, at least to me, was a collection of 8 mm Eastern European travel films which The Quay's collected as inspiration for their work; these grainy and blurred snatches of dark and forgotten streets, shop windows with wax mannequin heads, and church interior possess much of the atmosphere, mystery, and powerful detail evident the Quay's best works; they serve as both an excellent introduction to the exhibition and an illuminating key to their film work.

If you are able to visit the exhibition--which I very highly recommend!--make very sure not to miss the bottom floor portion of the exhibit, where you will find a collection of The Quay Brother's dioramic film decors installed in what feels like a furtive peepshow, a sort of perverse and surrealistic Musée Mécanique. Here you can immerse yourself in the tiny and exquisite sets from such films as Street of Crocodiles; Le Bourgeois Gentilhomme; The Piano Tuner of Earthquakes; and The Cabinet of Jan Svankmajer; their wealth of detail rewards a careful and slow eye. Also, make sure to set some time aside to watch the films, many of which play in mini-theatres set up within the exhibition; the ballet piece The Sandman was an especial revelation to this viewer; dance and the Quays go surprisingly well together.

As we see in this exhibition, the through line of The Quay's long and storied careers--which has spanned drawing, painting, film, animation, theater and graphic design, and dioramic "film decors"-- is a sense of mysterious and compelling atmosphere created by an exacting and exquisite attention to detail: the craquelure of antique objects, a perfectly fractured piece of glass, the patina of caked on dirt, the hand-rendered imperfection of calligraphic script, the artful use of shadow, and, above all, a wonderful wit and humor that counterbalances the unapologetic inscrutability of the work. Do not miss this exhibition! You will never look at the work of the Quay Brothers the same way again. In a good way!

The exhibition will be on view at New York Museum of Modern Art from August 12–January 7.You can find out about the exhibition here. Also, the museum will be hosting a series of screenings of Quay Brothers films running the duration of the exhibition; you can find out more about that here.

All above images were taken in the exhibition.

Source:
http://morbidanatomy.blogspot.com/feeds/posts/default?alt=rss

"Objectify This: Female Anatomy Dissected and Displayed," Exhibition Curated by Street Anatomy's Vanessa Ruiz, September 7-29, Chicago

Just received notice of the very exciting looking exhibition "Objectify This: Female Anatomy Dissected" curated by Vanessa Ruiz, founder of the wonderful Street Anatomy Blog; images from the show above, and full info follows:

'OBJECTIFY THIS: Female Anatomy Dissected and Displayed', a group exhibition of paintings and illustrations featuring the underlying anatomy of the female body.

September 7th – September 29th
Design Cloud Gallery
118 N. Peoria St. 2N, Chicago, IL

Opening event Friday, September 7th, 6–10p.m. with burlesque performances by Chicago's Vaudezilla troupe.

Throughout time, female anatomical illustration has evoked a multitude of feelings beyond simple academic representation. It's one of the reasons why the male form has been the exemplum of the human body throughout time, with the female being illustrated only as the variation in terms of reproductive organs and surface anatomy. This gallery show seeks to portray females only in relation to other females. It will compel viewers to question the objectivity surrounding ‘female anatomy’ and define—or re-define—their own perceptions through the art, perspectives, literature, and live burlesque performances.

Featured artists: Fernando Vicente, Jason Levesque, Cake, Michael Reedy, Emily Evans, Danny Quirk, Pole Ka, Tristan des Limbes, Amylin Loglisci.

You can find out more by clicking here.

Images, Top to bottom (click on images to see larger version):

  1. "American Housewife" by Fernando Vicente
  2. "Anatomical Meluxine" by Jason Levesque, 2012
  3. "Christina" by Danny Quirk, 2010

Source:
http://morbidanatomy.blogspot.com/feeds/posts/default?alt=rss

On The Curious Victorian Phenomenon of Exactingly Produced Miniature Butcher Shops, Collector's Weekly, 2012

PETA would never approve: This grisly 1840 doll-sized butcher shop with miniature animal carcasses and a floor covered in sawdust and blood would be shockingly graphic to our modern sensibilities. After all, here in the 21st century, we like to remain cheerfully oblivious about where our meat products come from.

But in Victorian times, such detailed model butcher shops were not uncommon, says Sarah Louise Wood, a curator at the Museum of Childhood at the Victoria and Albert Museum in London. The real question is: Why exactly do such things exist?
--Baby’s First Butcher Shop, Circa 1900, Collector's Weekly, Lisa Hix

Find out more by about this forgotten art by reading the entirety of "Baby’s First Butcher Shop, Circa 1900"  on the Collector's Weekly website by clicking here.

All images drawn from the Collector's Weekly website. You can see larger copies by clicking on images, and find out more by clicking here.

Source:
http://morbidanatomy.blogspot.com/feeds/posts/default?alt=rss

Libertarian Party can't get traction; despite Nevada's leanings, party lags in registration

Gary Johnson is interviewed Tuesday at the Reno Gazette-Journal. / Liz Margerum/RGJ Libertarians approach politics based on the moral principle of self-ownership. Each individual has the right to control his or her own body, action, speech and property.

View post:

Libertarian Party can't get traction; despite Nevada's leanings, party lags in registration